HLA-DR alleles display sex-dependent effects on survival and discriminate between individual and familial longevity

Human Molecular Genetics

Volumn 7, Issue 2, 1998, Pages 187-194

  Ivanova, Rayna ^a   Hénon, Nicolas ^b   Lepage, Virginia ^a   Charron, Dominique ^a   Vicaut, Eric ^c   Schächter, François ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b FONDATION JEAN DAUSSET CEPH   (France)

^c HÔPITAL FERNAND WIDAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FRANCE; GENE FREQUENCY; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; LONGEVITY; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; POPULATION GENETICS; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALLELES; COHORT STUDIES; FAMILY HEALTH; FEMALE; FRANCE; GENE FREQUENCY; GENES, MHC CLASS II; GENOTYPE; HLA-DR ANTIGENS; HUMANS; LOGISTIC MODELS; LONGEVITY; MALE; POLYMORPHISM, GENETIC; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 0031964576     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/7.2.187     Document Type: Article

References (68)

1. Schächter, F., Cohen, D. and Kirkwood, T. (1993) Prospects for the genetics of human longevity. Hum. Genet., 91, 519-526.
2. Herskind, A.M., Mcgue, M., Holm, N.V., Sorensen, T.I.A., Harvald, B. and Vaupel, J.W. (1996) The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum. Genet., 97, 319-323.
3. Schächter, F., Faure-Delanef, L., Guénot, F., Rouger, H., Froguel, P., Lesueur-Ginot, L. and Cohen, D. (1994) Genetic associations with longevity at the APOE and ACE loci. Nature Genet., 6, 29-32.
4. Kervinen, K., Savolainen, M.J., Salokannel, J., Hynninen, A., Heikkinen, J., Ehnholm, C., Koistinen, M.J. and Kesaniemi, Y.A. (1994) Apolipoprotein E and B polymorphisms - longevity factors assessed in nonagenarians. Atherosclerosis, 105, 89-95.
5. Mari, D., Mannucci, P.M., Duca, F., Bertolini, S. and Franceschi, C. (1996) Mutant factor V (Arg506Gln) in healthy centenarians. Lancet, 347, 1044.
6. Toro, A.I. and Ossa, J. (1996) PCR activity of CMV in healthy CMV-seropositive individuals: does latency need a redefinition? Res. Virol., 147, 233-238.
7. Smith, G.S. and Watford, R.L. (1977) Influence of the main histocompatibility complex on ageing in mice. Nature, 270, 727-729.
8. Yunis,E.J. and Salazar, M. (1993) Genetics of life span in mice. Genetica, 91, 211-223.
9. Macurova, H., Ivanyi, P., Sajdlova, H. and Trojan, J. (1975) HLA antigens in aged persons. Tissue Antigens, 6, 269-271.
10. Drouet, E., Colimon, R., Michelson, S., Fourcade, N., Niveleau, A., Ducere, C., Boibieux, A., Chevallier, M. and Denoyel, G. (1995) Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation. J. Clin. Microbiol., 33, 389-394.
11. Yarnell, J.W., St Leger, A.S., Balfour, I.C. and Russell, R.B. (1979) The distribution, age effects and disease associations of HLA antigens and other blood group markers in a random sample of an elderly population. J. Chron. Dis., 32, 555-561.
12. Proust, J., Moulias, R., Fumeron, F., Bekkhoucha, F., Busson, M., Schmid, M. and Hors, J. (1982) HLA and longevity. Tissue Antigens, 19, 168-173.
13. Gerkins, V.R., Ting, A. and Menck, H.T. (1974) HLA heterozygosity as a genetic marker of long-term survival. J. Natl Cancer Inst., 52, 1909-1911.
14. Blackwelder, W.C., Mittal, K.K., McNamara, P.M. and Payne, F.J. (1982) Lack of association between HLA and age in an aging population. Tissue Antigens, 20, 188-192.
15. Takata, H., Suzuki, M., Ishii, T., Sekiguchi, S. and Iri, H. (1987) Influence of major histocompatibility complex region genes on human longevity among Okinawan-Japanese centenarians and nonagenarians. Lancet, 824-826.
16. Lagaay, A.M., D'Amaro, J., Ligthart, G.J., Schreuder, G.M., Van Rood, J.J. and Hijmans,·W. (1991) Longevity and heredity in humans. Association with the human leukocyte antigen phenotype. Ann. NY Acad. Sci., 621, 78-89.
17. Yunis, E.J., Watson, A., Gelman, S.L., Sylvia, S.L., Bronson, R. and Dorf, D.E. (1984) Traits that influence longevity in mice. Genetics, 108, 99-1011.
18. Lerner, S.P. and Finch, C.E. (1991) The major histocompatibility complex and reproductive functions. Endocrine Rev., 12, 78-90.
19. Gozlan, J., Laporte, J.P., Lesage, S., Labopin, M., Najman, A.G. and Petit, J.C. (1997) Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures. J. Clin. Microbiol., 34, 2085-2088.
20. Grundy, J.E., Ehmst, A., Einsele, H., Emery, V.C., Hebart, H., Prentice, H.G. and Ljungman, P. (1996) A three-center European external quality control study of PCR detection of cytomegalovirus DNA in blood. J. Clin. Microbiol., 34, 1166-1170.
21. Dorak, M.T., Mills, K.I., Gaffney, D., Wilson, D.W.L., Henderson, N. and Burnett, A.K. (1994) Homozygous MHC genotypes and longevity. Hum. Hered., 44, 271-278.
22. Lepage, V., Lamm, L.U. and Charron, D. (1993) Molecular aspects of HLA class II and some autoimmune diseases. Eur: J. Immunogenet., 20, 153-164.
23. Meyer, J.M., Han, J., Singh, R. and Moxley, G. (1996) Sex influences on the penetrance of HLA shared-epitode genotypes for rheumatoid arthritis. Am. J. Hum. Genet., 58, 371-383.
24. Tait, B.D., Harrison, L.C., Drummond, B.P., Stewart, V., Varney, M.D. and Honeyman, M.C. (1995) HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus. Hum. Immunol., 42, 116-122.
25. Marshall, K.W., Lìu, A.F., Canales, J., Perahia, B., Jorgensen, B., Gantzos, R.D., Aguilar, B., Devaux, B. and Rothbard, J.B. (1994) Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J. Immunol., 4946-4957.
26. Wucherpfenning, K.W. and Strominger, J.L, (1995) Selective binding of self peptides to disease-association major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human auto-immune diseases. J. Exp. Med., 181, 1597-1601.
27. Truman, J.-P., Garban, F., Choqueux, C., Charron, D. and Mooney, N. (1996) HLA Class II signaling mediates cellular activation and programmed cell death. Exp. Hematol., 24, 1409-1415.
28. Rea, I.M. and Middleton, D. (1994) Is the phenotypic combination A1B8Cw7DR3 a marker for male longevity? J. Am. Geriatr. Soc., 42, 978-983.
29. Kraat, Y.J., Christiaans, M.H., Nieman, F.H., van den Berg-Loonen, P.M., van Hooff, J.P. and Bruggeman, C.A. (1994) Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy. Transpl. Int., 7, 362-367.
30. Schrier, R.D., Freeman, W.R., Wiley, C.A. and McCutchan, J.A. (1995) Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group. J. Clin. Invest., 95, 1741-1746.
31. Almarri, A. and Batchelor, J.R. (1994) HLA and hepatitis B infection. Lancet, 344, 1194-1195.
32. Weitkamp, L.R., Moss, A.J., Lewis, R.A., Hall, W.J., MacCluer, J.W., Schwartz, P.J., Locati, E.H., Tzivoni, D., Vincent, G.M., Robinson, J.L. et al. (1994) Analysis of HLA and disease susceptibility: chromosome 6 genes and sex influence long-QT phenotype. Am. J. Hum. Genet., 55, 1230-1241.
33. Fernandez-Arquero, M., Figueredo, M.A., Maluenda, C. and de la Concha, E.G. (1995) HLA-linked genes acting as additive susceptibility factors in celiac disease. Hum. Immunol., 42, 295-300.
34. Meddeb-Garnaoui, A., Zeliszewski, D., Mougenot, J.F., Djilali-Saiah, I., Caillat-Zucman, S., Dormoy, A., Gaudebout, C., Tongio, M.M., Baudon, J.J. and Sterkers, G. (1995) Reevaluation of the relative risk for susceptibility to celiac disease of HLA-DRB1, -DQA1, -DQB1, -DPB1, and -TAP2 alleles in a French population. Hum. Immunol., 43, 190-199.
35. Michalski, J.P., McCombs, C.C., Arai, T., Elston, R.C., Cao, T., McCarthy, C.F. and Stevens, F.M. (1996) HLA-DR, DQ genotypes of celiac disease patients and healthy subjects from the West of Ireland. Tissue Antigens, 47, 127-133.
36. Sollid, L.M. and Thorsby, E. (1990) The primary association of celiac disease to a given HLA-DQa/b heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. Tissue Antigens, 36, 136-130.
37. Reinshagen, M., Loeliger, C., Kuehnl, P., Weiss, U., Manfras, B.J., Alder, G. and Boehm, B.O. (1996) HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany. Gut, 38, 538-542.
38. Troussard, X., Valensi, F., Debert, C., Maynadie, M., Schillinger, F., Bonnet, P., Macintyre, E.A. and Flandrin, G. (1994) Persistent polyclonal lymphocylosis with binucleated B lymphocytes: a genetic predisposition. Br. J. Haemitol., 88, 275-280.
39. Rodriguez Perez, M., Gonzalez Dominguez, J., Mataran Perez, L. and Salvatierra Rios, D. (1993) HLA DR7 as a protective factor against gold salt toxicity in rheumatoid arthritis. Ann. Med. Intern., 10, 484-486.
40. Gladman, D.D. and Farewell, V.T. (1995) The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model. Arthritis Rheum., 38, 845-850.
41. Yanagawa, T., Mangklabruks, A. and De Groot, L.J. (1994) Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucasian population. J. Clin. Endocrinol. Metab., 79, 227-229.
42. Rigopoulou, D., Martinez-Laso, J., Martinez-Tello, F., Alcaide, J.F., Benmamar, D., Hawkins, F. and Amaiz-Villena, A. (1994) Both class I and class II HLA antigens are thyroid cancer susceptibility factors. Tissue Antigen, 43, 281-285.
43. Mariotti, S., Sansoni, P., Barbesino, G., Caturegli, P., Monti, D., Cossarizza, A., Giacomelli, T., Passeri, G., Fagiolo, U., Pinchera, A. and Franceschi, C. (1992) Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet, 339, 1506-1508.
44. Colombe, B.W., Price, V.H., Khoury, E.L., Garovoy, M.R. and Lou, C.D. (1995) HLA class II antigen associations help to define two types of alopecia areata. J. Am. Acad. Dermatol., 33, 757-764.
45. Annino, L., Ferrari, A., Laurenti, L., Perrone, M.P., Romani, C., Pacchiarotti, A., Girelli, G. and Mandelli, F. (1994) HLA typing in hairy cell leukemia. Leuk. Lymphoma, 14 (Suppl. 1), 63-65.
46. Cucca, F., Congia, M., Trowsdale, J. and Powis, S.H. (1994) Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAPI and TAP2: no association in a population with a high disease incidence. Tissue Antigens, 44, 234-240.
47. Buyse, I., Sandkuyl, L.A., Zamani Ghabanbasani, M., Gu, X.X., Bouillon, R., Bex, M., Dooms, L., Emonds, M.P., Duhamel, M., Marynen, P. et al. (1994) Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population. Diabetologia, 37, 808-817.
48. Hill, A.V.S., Allsopp, C., Kwiatkowski, D. and Anstey, N.M. (1991) Common West African HLA antigens are associated with protection from severe malaria. Nature, 352, 595-600.
49. Thursz, M., Kwiatkoski, D., Allsopp, C., Greenwood, B., Thomas, H. and Hill, A. (1995) Association between an MHC class-II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med., 332, 1065-1069.
50. Davenport, M.P., Quinn, C.L., Chicz, R.M., Green, B.N., Willis, A.C., Lane, W.S., Bell, J.I. and Hill, A.V. (1995) Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. Proc. Natl Acad. Sci. USA, 92, 6567-6571.
51. Winchester, R., Chen, Y., Rose, S., Selby, J. and Borkowsky, W. (1995) Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method. Proc. Natl Acad. Sci. USA, 92, 12374-12378.
52. Apple, R.J., Erlich, H.A., Klitz, W., Manos, M.M., Becker, T.M. and Wheeler, C.M. (1994) HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet., 6, 157-162.
53. Sastre-Garau, X., Loste, M.N., Vincent-Salomon, A., Favre, M., Mouret, E., de la Rochefordiere, A., Durand, J.C., Tartour, E., Lepage, V. and Charron, D. (1996) Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int. J. Cancer, 69, 159-164.
54. Haegert, D.G., Swift, F.V. and Benedikz, J. (1996) Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology, 46, 1107-1111.
55. Kirkwood, TB.L. and Rose, M.R. (1991) Evolution of senescence: late survival sacrified for reproduction. Phil. Trans. R. Soc: London B, 332, 15-24.
56. Robine, J .M. and Allard, M. (1995) Validation of the exceptional longevity case of 120 year old woman. Facts Res. Gerontol., 363-367.
57. Wyshak, G. (1978) Fertility and longevity in twins, sibs, and parents of twins. Soc. Biol., 25, 315-330.
58. Carmelli, D. (1982) Intrapair comparisons of total life span in twins and pairs of sibs. Hum. Biol., 54, 525-537.
59. Walford, R.L. (1987) In Warner, H.L., Butler, R.N., Sprott, R.L. and Schneider, E.L., eds. Modern Biological Theories of Aging. Raven Press, New York, pp. 243-260.
60. Walford, R.L. (1990) In Finch, C.E. and Johnson, T.E., eds. Molecular Biology of Aging. Wiley-Liss, New York, pp. 31-41.
61. Corzo, D., Salazar, M., Granja, C.B. and Yunis, E.J. (1995) Advances in HLA genetics. Exp. Clin. Immunogenet., 12, 156-170.
62. Finch, C.E. and Rose, M.R. (1995) Hormones and the physiological architecture of life history evolution. Q. Rev. Biol., 70, 1-52.
63. Crew, M.D. (1993) Genes of the Major Histocompatibility Complex and the evolutionary genetics of lifespan. Genetica, 91, 225-238.
64. Svejgaard, A. and Ryder, L.P. (1994) HLA and disease associations: detecting the strongest association. Tissue Antigens, 43, 18-27.
65. Tomlinson, I.P.M. and Bodmer, W.F. (1995) The HLA system and the analysis of multifactorial genetic disease. Trends Genet., 11, 493-498.
66. Benazet, J.-F., Reviron, D., Mercier, P., Roux, H. and Roudier, J. (1995) HLA-DRB1 alleles associated with rheumatoid arthritis in southern France. Absence of extraarticular disease despite expression of the shared epitope. J. Rheumatol., 22, 607-610.
67. Raguns, O., Mercier, B., Cldes, J., Whebe, B. and Free, C. (1995) HLA class II typing and idiopathic IgA nephropathy (IgAN): DQB1*0301, a possible marker of unfavourable outcome. Tissue Antigens, 45, 246-249.
68. Lepage, V., Schaeffer, V., Mallet, C., Ivanova, R., Khalil, I. and Charron, D. (1994) Determination of DRB alleles using PCR amplification and allele specific primers. Eur: J. Immunogenet., 21, 1-13.